METIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)
A study for patients with brain metastases from non-small cell lung cancer (NSCLC) using radiosurgery
Sponsor: NovoCure Ltd.
Enrolling: Male and Female Patients
IRB Number: AAAR1011
U.S. Govt. ID: NCT02831959
Contact: Teri Kreisl: 212-342-0571 /
Additional Study Information: The purpose of this study is to obtain information on the safety and effectiveness of NovoTTF-100M (study device) in subjects with brain metastases (tumors) as a result of non-small cell lung cancer (NSCLC).
This study is closed
Teri Kreisl, MD
Do You Qualify?
Have you been diagnosed with a brain tumor as a result of having NSCLC? Yes No
Are you at least 18 years of age? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Teri Kreisl